qSVA framework for RNA quality correction in differential expression analysis.

Area of Science:

• Genomics
• Bioinformatics
• Molecular Biology

Background:

• RNA sequencing (RNA-seq) is vital for measuring gene expression but sensitive to RNA quality.
• Existing quality control methods often fail to correct for RNA degradation bias when it correlates with study outcomes.
• This limitation can confound differential gene expression analysis in human tissues.

Purpose of the Study:

• To develop and validate a method to correct for RNA degradation effects in RNA-seq data.
• To improve the reliability and reproducibility of differential gene expression analyses.
• To address confounding factors in transcriptomic studies using human tissues.

Main Methods:

• Utilized RNA-seq data from molecular degradation experiments on human primary tissues.
• Introduced quality surrogate variable analysis (qSVA) as a statistical framework.
• Applied qSVA to estimate and remove the confounding effects of RNA quality.

Main Results:

• Demonstrated that qSVA effectively removes RNA degradation biases.
• Achieved over a threefold improvement in replication rates in independent schizophrenia brain studies.
• Successfully corrected biases in previously published comparative studies of brain regions and diagnostic groups.

Conclusions:

• qSVA provides a robust framework for correcting RNA quality confounding in RNA-seq.
• This method enhances the accuracy and interpretability of differential gene expression analyses.
• qSVA is crucial for reliable transcriptomic research using human tissue samples.